These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21164491)

  • 1. Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats.
    Pelisch N; Hosomi N; Ueno M; Nakano D; Hitomi H; Mogi M; Shimada K; Kobori H; Horiuchi M; Sakamoto H; Matsumoto M; Kohno M; Nishiyama A
    Am J Hypertens; 2011 Mar; 24(3):362-8. PubMed ID: 21164491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS inhibition attenuates cognitive impairment by reducing blood- brain barrier permeability in hypertensive subjects.
    Pelisch N; Hosomi N; Mori H; Masaki T; Nishiyama A
    Curr Hypertens Rev; 2013 May; 9(2):93-8. PubMed ID: 23971690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
    Rafiq K; Nishiyama A; Konishi Y; Morikawa T; Kitabayashi C; Kohno M; Masaki T; Mori H; Kobori H; Imanishi M
    PLoS One; 2014; 9(9):e107853. PubMed ID: 25233358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II AT₁-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats.
    Kosaka S; Pelisch N; Rahman M; Nakano D; Hitomi H; Kobori H; Fukuoka N; Kobara H; Mori H; Masaki T; Cervenka L; Matsumura Y; Houchi H; Nishiyama A
    J Pharmacol Sci; 2013; 121(2):95-102. PubMed ID: 23337436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
    Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
    J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
    Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Waki H; Maeda M; Ogawa H; Kim-Mitsuyama S
    Atherosclerosis; 2014 Sep; 236(1):101-7. PubMed ID: 25016364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.
    Li L; Guan Y; Kobori H; Morishita A; Kobara H; Masaki T; Nakano D; Nishiyama A
    Hypertens Res; 2019 Jun; 42(6):769-778. PubMed ID: 30587856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.
    Zhou MS; Schulman IH; Raij L
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H833-9. PubMed ID: 19151253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model.
    Kim-Mitsuyama S; Izumi Y; Izumiya Y; Yoshida K; Yoshiyama M; Iwao H
    Hypertens Res; 2004 Oct; 27(10):771-9. PubMed ID: 15785013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High salt intake and the brain renin--angiotensin system in Dahl salt-sensitive rats.
    Zhao X; White R; Huang BS; Van Huysse J; Leenen FH
    J Hypertens; 2001 Jan; 19(1):89-98. PubMed ID: 11204309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
    Awad AS
    Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan.
    Kiya Y; Miura S; Fujino M; Imaizumi S; Karnik SS; Saku K
    Clin Exp Hypertens; 2010 Jan; 32(2):129-36. PubMed ID: 20374187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
    J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
    Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
    Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats.
    Chen X; Mori T; Guo Q; Hu C; Ohsaki Y; Yoneki Y; Zhu W; Jiang Y; Endo S; Nakayama K; Ogawa S; Nakayama M; Miyata T; Ito S
    Hypertens Res; 2013 Apr; 36(4):361-7. PubMed ID: 23364337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
    Nagai Y; Yao L; Kobori H; Miyata K; Ozawa Y; Miyatake A; Yukimura T; Shokoji T; Kimura S; Kiyomoto H; Kohno M; Abe Y; Nishiyama A
    J Am Soc Nephrol; 2005 Mar; 16(3):703-11. PubMed ID: 15647337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.